• Molecular NamePhenindamine
  • SynonymFenindamina [inn-spanish]; Phenindaminum [inn-latin]; Phenindiamine
  • Weight261.368
  • Drugbank_IDDB01619
  • ACS_NO82-88-2
  • Show 2D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)4.4
  • pka8.3 (25°)
  • LogD (pH=7, predicted)2.86
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-2.29
  • LogSw (predicted, AB/LogsW2.0)0.0
  • Sw (mg/ml) (predicted, ACD/Labs)0.05
  • No.of HBond Donors0
  • No.of HBond Acceptors1
  • No.of Rotatable Bonds1
  • TPSA3.24
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyAn antihistamine closely related to cyproheptadine used to treat symptoms of the common cold and allergies, such as sneezing, itching, rashes, and hives.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A